Methods for adhering tissue surfaces and materials and biomedical uses thereof

1. A method for adhering a biological tissue surface to a second surface in a subject in need thereof, comprising the steps of

providing nanoparticles in the form of a powder on at least one of the biological tissue surface and the second surface,

bringing the biological tissue surface and the second surface into contact for a time sufficient for the biological tissue surface and the second surface to adhere to each other, and

optionally verifying placement, maintenance and/or biodegradation of the nanoparticles using at least one imaging technique;

wherein the second surface is a hydrogel scaffold,

wherein the nanoparticles are silica nanoparticles or iron oxide nanoparticles having a size in the range of 2 to 500 nanometers, and

wherein the powder does not include a coagulation agent added to the nanoparticles.

2. The method of claim 1 wherein the biological tissue surface is selected from the group consisting of skin tissue, hair tissue, nail tissue, corneal tissue, tongue tissue, oral cavity tissue, esophageal tissue, anal tissue, urethral tissue, vaginal tissue, urinary epithelial tissue, salivary gland tissue, mammary gland tissue, lacrimal gland tissue, sweat gland tissue, prostate gland tissue, bulbourethral gland tissue, Bartholin's gland tissue, uterine tissue, respiratory and gastrointestinal tract goblet cell tissue, gastric mucosal tissue, gastric gland tissue, pancreatic tissue, spleen tissue, pulmonary tissue, pituitary gland tissue, thyroid gland tissue, parathyroid gland tissue, testicular tissue, ovarian tissue, respiratory gland tissue, gastrointestinal gland tissue, adrenal gland tissue, renal tissue, liver tissue, adipose tissue, duct cell tissue, gall bladder tissue, epidydimal tissue, vas deferens tissue, blood vessel tissue, lymph gland tissue, lymphatic duct tissue, synovial tissue, serosal tissue, squamous tissue, cochlear tissue, choroid plexus tissue, ependymal tissue, dural tissue, pia-arachnoid tissue, sclera tissue, retinal tissue, iris tissue, ciliary tissue, dental tissue, otic tissue, ligament tissue, tendon tissue, elastic cartilage tissue, fibrocartilage tissue, hyaline cartilage tissue, bone marrow tissue, intervertebral disc tissue, compact bone tissue, cancellous bone tissue, skeletal muscle tissue, cardiac muscle tissue, smooth muscle tissue, cardiac valve tissue, pericardial tissue, pleural tissue, peritoneal tissue, blood cell tissue, neuronal tissue, glial tissue, sensory transducer cell tissue, pain sensitive tissue, autonomic neuron tissue, peripheral nervous system tissue, cranial nerve tissue, ocular lens tissue, germ cell tissue, thymus tissue, placental tissue, fetal membrane tissue, umbilical tissue, stem cell tissue, mesodermal tissue, ectodermal tissue, endodermal tissue, autologous tissue, allograft tissue and a combination thereof.

3. The method of claim 1 , wherein the hydrogel scaffold further comprises a biologically active agent, a pharmaceutical agent or a radiosensitizer.

4. The method of claim 1 , wherein the hydrogel scaffold is loaded with a plurality of cells.

5. The method according to claim 1 , wherein the nanoparticles are provided on the biological tissue surface and/or the second surface with a technique selected from the group consisting of coating, dipping, spraying, spreading and pouring.

6. The method according to claim 1 , wherein the nanoparticles are provided on the biological tissue surface with means selected from the group consisting of a patch, a dressing, an elastic bandage and an adhesive strip with a gauze pad having a plurality of capsules having the ability to release the nanoparticles when they are contacted by the biological tissue.

7. The method according to claim 1 , further comprising providing silica or iron oxide nanoparticles on both the biological tissue surface and the second surface, prior to bringing the biological tissue surface and second surface into contact.

8. The method according claim 1 , wherein the powder comprising the nanoparticles further comprises a powdered drug to treat infection or malignancy or promote tissue regeneration.

9. The method according to claim 1 , wherein the method is performed as part of at least one procedure selected from the group consisting of bariatric surgery, cardiac surgery, thoracic surgery, colon and rectal surgery, dermatologic surgery, general surgery, gynecologic surgery, maxillofacial surgery, neurosurgery, obstetric surgery, oncologic surgery, ophthalmologic surgery, oral surgery, orthopedic surgery, otolaryngologic surgery, pediatric surgery, plastic surgery, cosmetic and reconstructive surgery, podiatric surgery, spine surgery, transplant surgery, trauma surgery, vascular surgery, urologic surgery, dental surgery, veterinary surgery, endoscopic surgery, anesthesiology, an interventional radiologic procedure, an emergency medicine procedure, a battlefield procedure, a deep or superficial laceration repair, a cardiologic procedure, an internal medicine procedure, an intensive care procedure, an endocrinologic procedure, a gastroenterologic procedure, a hematologic procedure, a hepatologic procedure, a diagnostic radiologic procedure, an infectious disease procedure, a nephrologic procedure, an oncologic procedure, a proctologic procedure, a pulmonary medicine procedure, a rheumatologic procedure, a pediatric procedure, a physical medicine or rehabilitation medicine procedure, a geriatric procedure, a palliative care procedure, a medical genetic procedure and a fetal procedure.

10. A method for adhering a biological tissue surface to a hydrogel scaffold in a subject in need thereof, comprising the steps of

providing nanoparticles in the form of a powder on at least one of the biological tissue surface and the hydrogel scaffold, wherein the nanoparticles are silica nanoparticles or iron oxide nanoparticles having a size in the range of 2 to 500 nanometers and wherein the powder does not include a coagulation agent added to the nanoparticles;

bringing the biological tissue surface and the hydrogel scaffold into contact for a time sufficient for the biological tissue surface and the hydrogel scaffold to adhere to each other; and

verifying placement, maintenance and/or biodegradation of the nanoparticles using at least one imaging technique able to detect the nanoparticles, wherein the at least one imaging technique is selected from the group consisting of ultrasonography, elastography, supersonic shear wave imaging, magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), fluorescence spectroscopy, computed tomography and X-ray radiography.